208 related articles for article (PubMed ID: 18023586)
21. The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar.
Brent MB; Thomsen JS; Brüel A
Front Endocrinol (Lausanne); 2020; 11():588773. PubMed ID: 33162940
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of an injectable bone substitute (betaTCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely osteopenic and aged rats.
Blouin S; Moreau MF; Weiss P; Daculsi G; Baslé MF; Chappard D
J Biomed Mater Res A; 2006 Sep; 78(3):570-80. PubMed ID: 16739169
[TBL] [Abstract][Full Text] [Related]
23. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats.
Iwamoto J; Yeh JK; Takeda T
J Bone Miner Res; 2003 Apr; 18(4):776-83. PubMed ID: 12674339
[TBL] [Abstract][Full Text] [Related]
24. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
Iwamoto J; Takeda T; Sato Y; Yeh JK
Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
[TBL] [Abstract][Full Text] [Related]
25. The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment.
Callaci JJ; Juknelis D; Patwardhan A; Sartori M; Frost N; Wezeman FH
Alcohol Clin Exp Res; 2004 Jan; 28(1):182-91. PubMed ID: 14745317
[TBL] [Abstract][Full Text] [Related]
26. Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice.
Sørensen TG; Brent MB; Thomsen JS; Brüel A
Bone; 2020 Feb; 131():115183. PubMed ID: 31794846
[TBL] [Abstract][Full Text] [Related]
27. Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
Exp Anim; 2006 Jul; 55(4):349-55. PubMed ID: 16880682
[TBL] [Abstract][Full Text] [Related]
28. High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse.
Yang Li C; Majeska RJ; Laudier DM; Mann R; Schaffler MB
Bone; 2005 Sep; 37(3):287-95. PubMed ID: 16006205
[TBL] [Abstract][Full Text] [Related]
29. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
[TBL] [Abstract][Full Text] [Related]
30. Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography.
Dufresne TE; Chmielewski PA; Manhart MD; Johnson TD; Borah B
Calcif Tissue Int; 2003 Nov; 73(5):423-32. PubMed ID: 12964065
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats.
Grubbe MC; Thomsen JS; Nyengaard JR; Duruox M; Brüel A
J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):473-83. PubMed ID: 25524973
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226
[TBL] [Abstract][Full Text] [Related]
33. Feeding orange pulp improved bone quality in a rat model of male osteoporosis.
Morrow R; Deyhim F; Patil BS; Stoecker BJ
J Med Food; 2009 Apr; 12(2):298-303. PubMed ID: 19459729
[TBL] [Abstract][Full Text] [Related]
34. PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats.
Brüel A; Vegger JB; Raffalt AC; Andersen JE; Thomsen JS
Bone; 2013 Mar; 53(1):51-8. PubMed ID: 23246791
[TBL] [Abstract][Full Text] [Related]
35. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography.
Borah B; Dufresne TE; Chmielewski PA; Gross GJ; Prenger MC; Phipps RJ
J Bone Miner Res; 2002 Jul; 17(7):1139-47. PubMed ID: 12096826
[TBL] [Abstract][Full Text] [Related]
36. The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
Donner DG; Elliott GE; Beck BR; Forwood MR; Du Toit EF
Osteoporos Int; 2016 Mar; 27(3):1073-1082. PubMed ID: 26438310
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis.
Gabet Y; Müller R; Levy J; Dimarchi R; Chorev M; Bab I; Kohavi D
Bone; 2006 Aug; 39(2):276-82. PubMed ID: 16617039
[TBL] [Abstract][Full Text] [Related]
38. Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats.
Sun P; Cai DH; Li QN; Chen H; Deng WM; He L; Yang L
Calcif Tissue Int; 2010 Jun; 86(6):495-501. PubMed ID: 20390406
[TBL] [Abstract][Full Text] [Related]
39. High-resolution three-dimensional micro-computed tomography detects bone loss and changes in trabecular architecture early: comparison with DEXA and bone histomorphometry in a rat model of disuse osteoporosis.
Barou O; Valentin D; Vico L; Tirode C; Barbier A; Alexandre C; Lafage-Proust MH
Invest Radiol; 2002 Jan; 37(1):40-6. PubMed ID: 11753153
[TBL] [Abstract][Full Text] [Related]
40. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S
J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
